Emerging zoonoses and vector-borne infections affecting humans in Europe

Epidemiology and Infection

Volumn 135, Issue 8, 2007, Pages 1231-1247

  Vorou, R M ^a,c   Papavassiliou, V G ^a   Tsiodras, S ^a,b  

^a Hellenic Center for Disease Control and Prevention   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TICK BORNE ENCEPHALITIS VACCINE;

ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ARTHRITIS; AVIAN INFLUENZA; BACTERIUM CARRIER; BARTONELLA; BORRELIA BURGDORFERI; CLIMATE CHANGE; DISEASE CARRIER; ECHINOCOCCUS MULTILOCULARIS; EPIDEMIC; EUROPE; FRANCISELLA TULARENSIS; HANTAVIRUS; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFORMATION RETRIEVAL; LUNG HYDATID CYST; LYME DISEASE; MEDLINE; NAIRO VIRUS; NONHUMAN; PARASITE VECTOR; POPULATION DYNAMICS; PREVALENCE; REVIEW; RICKETTSIA; RICKETTSIOSIS; RISK FACTOR; SINDBIS VIRUS; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; TRICHINELLA; TRICHINOSIS; TULAREMIA; VARIANT CREUTZFELDT JAKOB DISEASE; VIRUS CARRIER; VIRUS HEMORRHAGIC FEVER; WEST NILE FLAVIVIRUS; ZOONOSIS; ANIMAL; COMMUNICABLE DISEASE; DISEASE TRANSMISSION;

ANIMALS; COMMUNICABLE DISEASES, EMERGING; DISEASE VECTORS; EUROPE; HUMANS; RISK FACTORS; ZOONOSES;

EID: 38449090103     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008527     Document Type: Review

References (177)

1. Cunningham AA. A walk on the wild side - emerging wildlife diseases. British Medical Journal 2005; 331: 1214-1215.
2. Blancou J, et al. Emerging or re-emerging bacterial zoonoses: Factors of emergence, surveillance and control. Veterinary Research 2005; 36: 507-522.
3. Report of the WHO/FAO/OIE Joint Consultation on Emerging Zoonotic Diseases. 3-5 May 2004, Geneva, Switzerland (http://whqlibdoc.who.int/hq/2004/WHO_CDS_CPE_ZFK_2004.9.pdf). Accessed 15 August 2006.
4. Hughes JM. Emerging infectious diseases: A CDC perspective. Emerging Infectious Diseases 2001; 7: 494-496.
5. Mehnert WH, Krause G. Surveillance of Lyme borreliosis in Germany, 2002 and 2003. Eurosurveillance 2005; 10: 83-85.
6. Santino I, et al. Multicentric study of seroprevalence of Borrelia burgdorferi and Anaplasma phagocytophila in high-risk groups in regions of central and southern Italy. International Journal of Immunopathology and Pharmacology 2004; 17: 219-223.
7. Nygard KK, Brantsaeter AB, Mehl R. Disseminated and chronic Lyme borreliosis in Norway, 1995-2004. Eurosurveillance 2005; 10: 235-238.
8. Stefancikova A, et al. Anti-Borrelia antibodies in rodents: important hosts in ecology of Lyme disease. Annals of Agricultural and Environmental Medicine 2004; 11: 209-213.
9. Reed KD, et al. Birds, migration and emerging zoonoses: West Nile virus, Lyme disease, Influenza A and Enteropathogens. Clinical Medicine & Research 2003; 1: 5-12.
10. Olsen B, et al. Transhemispheric exchange of Lyme disease spirochetes by seabirds. Journal of Clinical Microbiology 1995; 33: 3270-3274.
11. Foldvari G, Farkas R, Lakos A. Borrelia spielmanii erythema migrans, Hungary. Emerging Infectious Diseases 2005; 11: 1794-1795.
12. Richter D, et al. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe. Applied Environmental Microbiology 2004; 70: 6414-6419.
13. Piccolin G, et al. A Study of the presence of B. burgdorferi, Anaplasma (previously ehrlichia) phagocytophilum, Rickettsia, and Babesia in Ixodes ricinus collected within the territory of Belluno, Italy. Vector Borne and Zoonotic Diseases 2006; 6: 24-31.
14. Avidor B, et al. Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. Journal of Clinical Microbiology 2004; 42: 3462-3468.
15. Boulouis HJ, et al. Factors associated with the rapid emergence of zoonotic Bartonella infections. Veterinary Research 2005; 36: 383-410.
16. Tea A, et al. Bartonella species isolated from rodents, Greece. Emerging Infectious Diseases 2004; 10: 963-964.
17. Engbaek K, Lawson PA. Identification of Bartonella species in rodents, shrews and cats in Denmark: Detection of two B. henselae variants, one in cats and the other in the long-tailed field mouse. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2004; 112: 336-341.
18. Melter O, et al. Detection and characterization of feline Bartonella henselae in the Czech Republic. Veterinary Microbiology 2003; 93: 261-273.
19. La VD, et al. Bartonella quintana in domestic cat. Emerging Infectious Diseases 2005; 11: 1287-1289.
20. Cross TJ, Penn RL. Francisella tularensis (tularemia). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th edn. Philadelphia, PA: Churchill Livingston, 2000; pp. 2393-2402.
21. Tarnvik A, Priebe HS, Grunow R. Tularaemia in Europe: An epidemiological overview. Scandinavian Journal of Infectious Diseases 2004; 36: 350-355.
22. Vaissaire J, et al. Tularemia. The disease and its epidemiology in France [in French]. Medecine et Maladies Infectieuses 2005; 35: 273-280.
23. Siret V, et al. An outbreak of airborne tularaemia in France, August 2004. Eurosurveillance 2006; 11: 58-60.
24. Perez-Castrillon JL, et al. Tularemia epidemic in northwestern Spain: Clinical description and therapeutic response. Clinical Infectious Diseases 2001; 33: 573-576.
25. Payne L. Endemic tularemia, Sweden, 2003. Emerging Infectious Diseases 2005; 11: 1440-1442.
26. Eliasson H, et al. The 2000 tularemia outbreak: A case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerging Infectious Diseases 2002; 8: 956-960.
27. Kantardjiev T, et al. Tularemia outbreak, Bulgaria, 1997 2005. Emerging Infectious Diseases 2006; 12: 678-680.
28. Reintjes R, et al. Tularemia outbreak investigation in Kosovo: Case control and environmental studies. Emerging Infectious Diseases 2002; 8: 69-73.
29. Hofstetter I, et al. Tularaemia outbreak in hare hunters in the Darmstadt-Dieburg district, Germany. Eurosurveillance 2006; 11: E060119.3 (http://www.eurosurveillance.org/ew/2006/ 060119.asp#2).
30. Petrovec M, et al. Human disease in Europe caused by a granulocytic Ehrlichia species. European Journal of Clinical Microbiology 1997; 35: 1556-1559.
31. Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clinical microbiology and infection (the official publication of the European Society of Clinical Microbiology and Infectious Diseases) 2002; 8: 763-772.
32. Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Veterinary Research 2005; 36: 469-492.
33. Stanczak J, et al. Ixodes ricinus as a vector of Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum and Babesia microti in urban and suburban forests. Annals of Agricultural and Environmental Medicine 2004; 11: 109-114.
34. Santos AS, et al. Detection of Anaplasma phagocytophilum DNA in Ixodes ticks (Acari: Ixodidae) from Madeira Island and Setubal District, mainland Portugal. Emerging Infectious Diseases 2004; 10: 1643-1648.
35. Parola P, et al. Ehrlichial DNA amplified from Ixodes ricinus (Acari: Ixodidae) in France. Journal of Medical Entomology 1998; 35: 180-183.
36. Petrovec M, et al. Infections of wild animals with Anaplasma phagocytophila in Austria and the Czech Republic. Annals of the New York Academy of Sciences 2003; 990: 103-106.
37. Bown KJ, et al. Seasonal dynamics of Anaplasma phagocytophila in a rodent-tick (Ixodes trianguliceps) system, United Kingdom. Emerging Infectious Diseases 2003; 9: 63-70.
38. Alberti A, et al. Anaplasma phagocytophilum, Sardinia, Italy. Emerging Infectious Diseases 2005; 11: 1322-1324.
39. Bjoersdorff A, et al. Ehrlichia-infected ticks on migrating birds. Emerging Infectious Diseases 2001; 7: 877-879.
40. Oporto B, et al. A survey on Anaplasma phagocytophila in wild small mammals and roe deer (Capreolus capreolus) in Northern Spain. Annals of the New York Academy of Sciences 2003; 990: 98-102.
41. Skarphedinsson S, Jensen PM, Kristiansen K. Survey of tickborne infections in Denmark. Emerging Infectious Diseases 2005; 11 1055-1061.
42. Cazorla C, et al. First isolation of Rickettsia slovaca from a patient, France. Emerging Infectious Diseases 2003; 9 135.
43. Oteo JA, et al. Epidemiological and clinical differences among Rickettsia slovaca rickettsiosis and other tick-borne diseases in Spain. Annals of the New York Academy of Sciences 2003; 990: 355-356.
44. Punda-Polic V, et al. Detection and identification of spotted fever group rickettsiae in ticks collected in southern Croatia. Experimental Applied Acarology 2002; 28: 169-176.
45. Nielsen H, et al. Serological and molecular evidence of Rickettsia helvetica in Denmark. Scandinavian Journal of Infectious Diseases 2004; 36: 559-563.
46. Fournier PE, et al. Evidence of Rickettsia helvetica infection in humans, eastern France. Emerging Infectious Diseases 2000; 6: 389-392.
47. Fournier PE, et al. Aneruptive fever associated with antibodies to Rickettsia helvetica in Europe and Thailand. Journal of Clinical Microbiology 2004; 42: 816-818.
48. Raoult D, et al. First documented human Rickettsia aeschlimannii infection. Emerging Infectious Diseases 2002; 8: 748-749.
49. Fernandez-Soto P, Encinas-Grandes A, Perez-Sanchez R. Rickettsia aeschlimannii in Spain: Molecular evidence in Hyalomma marginatum and five other tick species that feed on humans. Emerging Infectious Diseases 2003; 9: 889-890.
50. Shpynov SN, et al. Molecular identification of a collection of spotted Fever group rickettsiae obtained from patients and ticks from Russia. American Journal of Tropical Medicine and Hygiene 2006; 74: 440-443.
51. de Sousa R, et al. Rickettsia sibirica isolation from a patient and detection in ticks, Portugal. Emerging Infectious Diseases 2006: 12; 1103-1108.
52. Psaroulaki A, et al. Simultaneous detection of 'Rickettsia mongolotimonae' in a patient and in a tick in Greece. European Journal of Clinical Microbiology 2005; 43: 3558-3559.
53. Beninati T, et al. First detection of spotted fever group rickettsiae in Ixodes ricinus from Italy. Emerging Infectious Diseases 2002; 8: 983-986.
54. Sreter-Lancz Z, et al. Rickettsiae of the spotted-fever group in ixodid ticks from Hungary: Identification of a new genotype ('Candidatus Rickettsia kotlanii'). Annals of Tropical Medicine and Parasitology 2006; 100: 229-236.
55. Di rique Gouriet F, Rolain JM, Raoult D. Rickettsia slovaca infection, France. Emerging Infectious Diseases 2006; 12: 521-523.
56. Jaenson TG, et al. Geographical distribution, host associations, and vector roles of ticks (Acari: Ixodidae, Argasidae) in Sweden. Journal of Medical Entomology 1994; 31: 240-256.
57. Papa A, et al. Crimean-Congo hemorrhagic fever in Bulgaria. Emerging Infectious Diseases 2004; 10: 1465-1467.
58. Papa A, et al. Crimean-Congo hemorrhagic fever in Albania, 2001. European Journal of Clinical Microbiology and Infectious Diseases 2002; 21: 603-606.
59. Papa A, et al. Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerging Infectious Diseases 2002; 8: 852-854.
60. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infectious Diseases 2006; 6: 203-214.
61. Yashina L, et al. Genetic variability of Crimean-Congo haemorrhagic fever virus in Russia and Central Asia. Journal of General Virology 2003; 84: 1199-1206.
62. Yashina L, et al. Genetic analysis of Crimean-Congo Hemorrhagic fever virus in Russia. Journal of Clinical Microbiology 2003; 41: 860-862.
63. Lundkvist A, et al. Dobrava hantavirus outbreak in Russia. Lancet 1997; 350: 781-782.
64. Markotic A, et al. Characteristics of Puumala and Dobrava infections in Croatia. Journal of Medical Virology 2002; 66: 542-551.
65. Olsson GE, et al. Human hantavirus infections, Sweden. Emerging Infectious Diseases 2003; 9: 1395-1401.
66. Pal E, Strle F, Avsic-Zupanc T. Hemorrhagic fever with renal syndrome in the Pomurje region of Slovenia - an 18-year survey. Wiener klinische Wochenschrift 2005; 117: 398-405.
67. Alexeyev OA, et al. Hantaan and Puumala virus antibodies in blood donors in Samara, an HFRS-endemic region in European Russia. Lancet 1996; 347: 1483.
68. Sauvage F, et al. Puumala hantavirus infection in humans and in the reservoir host, Ardennes region, France. Emerging Infectious Diseases 2002; 8: 1509-1511.
69. Mailles A, et al. Larger than usual increase in cases of hantavirus infections in Belgium, France and Germany, June 2005. Eurosurveillance 2005; 10(7): E050721.4 (http://www.eurosurveillance.org/ew/2005/050721.asp#4).
70. Cvetko L, et al. Puumala virus in Croatia in the 2002 HFRS outbreak. Journal of Medical Virology 2005; 77: 290-294.
71. Rose AM, et al. Patterns of Puumala virus infection in Finland. Eurosurveillance 2003; 8: 9-13.
72. Schneider F, Mossong J. Increased hantavirus infections in Luxembourg, August 2005. Eurosurveillance 2005; 10(8): E050825.1 (http://www.eurosurveillance.org/ew/2005/050825.asp#1).
73. Hoier S, et al. Puumala virus RNA in patient with multiorgan failure [Letter]. Emerging Infectious Diseases 2006; 12: E050634.
74. Garanina SB, et al. Investigation of Hemorrhagic fever with renal syndrome outbreak in Udmutria, Russia. ICEID, 2006, 19-22 March, Atlanta, Georgia, USA. Poster session 46: Hemorrhagic fever. Abstract 275.
75. Lindgren E, Gustafson R. Tick-borne encephalitis in Sweden and climate change. Lancet 2001; 358: 16-18.
76. Peyrefitte CN, et al. Toscana virus and acute meningitis, France. Emerging Infectious Diseases 2005; 11: 778-780.
77. Sanbonmatsu-Gamez S, et al. Toscana virus in Spain. Emerging Infectious Diseases 2005; 11: 1701-1707.
78. Hemmersbach-Miller M, et al. Sandfly fever due to Toscana virus: An emerging infection in southern France. European Journal of Internal Medicine 2004; 15: 316-317.
79. Charrel RN, et al. Emergence of Toscana virus in Europe. Emerging Infectious Diseases 2005; 11: 1657-1663.
80. International Scientific Working group on TBE (http://www.tbe-info.com). Accessed 15 August 2006.
81. Kerbo N, Donchenko I, Kutsar K. Tickborne encephalitis outbreak in Estonia linked to raw goat milk, May-June 2005. Eurosurveillance 2005; 10(6): E050623.2 (http://www.eurosurveillance.org/ew/2005/ 050623.asp#2).
82. Beran J. Tickborne encephalitis in Europe: Czech Republic, Lithuania and Latvia. Eurosurveillance Weekly 2004; 6(26): 040624 (http://www.eurosurveillance.org/ew/2004/040624.asp#3).
83. Strauss R, et al. (Editorial team). Tickborne encephalitis in Europe: Basic information, country by country. Eurosurveillance Weekly 2004; 7(29): 040715 (http://www.eurosurveillance.org/ew/2004/040715.asp#2).
84. Csango PA, et al. Tick-borne encephalitis in southern Norway. Emerging Infectious Diseases 2004; 10: 533-534.
85. Daniel M, et al. Shift of the tick Ixodes ricinus and tick-borne encephalitis to higher altitudes in central Europe. European Journal of Clinical Microbiology and Infectious Diseases 2003; 22: 327-328.
86. Jaenson TG, et al. Geographical distribution, host associations, and vector roles of ticks (Acari: Ixodidae, Argasidae) in Sweden. Journal of Medical Entomology 1994; 31: 240-256.
87. Daniel M, et al. An attempt to elucidate the increased incidence of tick-borne encephalitis and its spread to higher altitudes in the Czech Republic. International Journal of Medical Microbiology 2004; 293 (Suppl. 37): 55-62.
88. Stefanoff P, et al. Evaluation of tickborne encephalitis case classification in Poland. Eurosurveillance 2005; 10: 23-25.
89. Gunther G, Lindquist L. Surveillance of tickborne encephalitis in Europe and case definition. Eurosurveillance 2005; 10: 23-25.
90. Morgue B, et al. West Nile in the Mediterranean basin: 1950-2000. Annals of the New York Academy of Sciences 2001; 951 117-126.
91. Hubalek Z, Halouzka J. West Nile fever - a reemerging mosquito-borne viral disease in Europe. Emerging Infectious Diseases 1999; 5: 643-650.
92. Platonov AE. West Nile encephalitis in Russia 1999-2001: Were we ready? Are we ready? Annals of the New York Academy of Sciences 2001; 951: 102-116.
93. Del Giudice P, et al. Human West Nile virus, France. Emerging Infectious Diseases 2004; 10: 1885-1886.
94. Zeller HG, Schuffenecker I. West Nile virus: An overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. European Journal of Clinical Microbiology and Inectious Diseases 2004; 23: 147-156.
95. Connell J, et al. Two linked cases of West Nile virus (WNV) acquired by Irish tourists in the Algarve, Portugal. Eurosurveillance Weekly 2004; 8(32): 040805 (http://www.eurosurveillance.org/ew/2004/040805.asp#1).
96. Charrel RN, et al. Evolutionary relationship between Old World West Nile virus strains. Evidence for viral gene flow between Africa, the Middle East, and Europe. Virology 2003; 315: 381-388.
97. Hayes EB, et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerging Infectious Diseases 2005; 11 1167-1173.
98. Autorino GL, et al. West Nile virus epidemic in horses, Tuscany region, Italy. Emerging Infectious Diseases 2002; 8: 1372-1378.
99. Bakonyi T, et al. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerging Infectious Diseases 2005; 11: 225-231.
100. Beasley DW, et al. Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology 2003; 309: 190-195.
101. Kurkela S, et al. Causative agent of Pogosta disease isolated from blood and skin lesions. Emerging Infectious Diseases 2004; 10: 889-894.
102. Laine M, et al. The prevalence of antibodies against Sindbis-related (Pogosta) virus in different parts of Finland. Rheumatology 2003; 42: 632-636.
103. Editorial team. Avian influenza H5N1 detected in German poultry and a United Kingdom wild bird. Eurosurveillance 2006; 11 4): E060406.1 (http://www.eurosurveillance.org/ew/2006/060406.asp#1).
104. Liu J, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 2005; 309: 1206.
105. Ducatez MF, et al. Avian flu: Multiple introductions of H5N1 in Nigeria. Nature 2006; 442: 37.
106. Coulombier D, Ekdahl K. H5N1 influenza and the implications for Europe. British Medical Journal 2005; 331: 413-414.
107. Quoifin S, et al. Management of potential human cases of influenza A/H5N1: Lessons from Belgium. Eurosurveillance Weekly 2006; 11: E060126 (http://www.eurosurveillance.org/ew/2006/ 060126.asp).
108. Editorial team. Avian influenza in Turkey: 21 confirmed human cases. Eurosurveillance 2006; 11: E060119.1 (http://www.eurosurveillance.org/ew/2006/060119.asp#l).
109. Giesecke J. Human cases of avian influenza in eastern Turkey: The weather factor. Eurosurveillance 2006; 11: E060119.2 (http://www.eurosurveillance.org/ew/2006/060119.asp#2).
110. Will RG, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921.
111. Britton, et al. Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK [Letter]. Lancet 1995; 346: 1155.
112. Chazot G, et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man [Letter; Comment]. Lancet 1996; 347 1181.
113. Colchester AC, Colchester NT. The origin of bovine spongiform encephalopathy: The human prion disease hypothesis. Lancet 2005; 366: 856-861.
114. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354: 317.
115. Ward HJ, et al Risk factors for variant Creutzfeldt-Jakob disease: A case-control study. Annals of Neurology 2006; 59: 111.
116. The BSE inquiry (http://www.bse.org.uk).
117. variant Creutzfeldt-Jakob Disease. Current data February 2007. (http://www.eurocjd.ed.ac.uk/vejdworldeuro.htm). Accessed 16 March 2007.
118. Llewelyn, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417.
119. Peden AH, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527.
120. Bird SM. Attributable testing for abnormal prion protein, database linkage, and blood-borne vCJD risks. Lancet 2004; 364: 1362.
121. Ludlam CA, Turner ML. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products. British Journal of Haematology 2006; 132: 13.
122. Perevoscikovs J, et al. Trichinellosis outbreak in Latvia linked to bacon bought at a market, January March 2005. Eurosurveillance 2005; 10(5): E050512.2 (http://www.eurosurveillance.org/ew/2005/050512.asp#2).
123. Bartuliene A, Jasulaitiene V, Malakauskas A. Human trichinellosis in Lithuania 1990-2004. Eurosurveillance 2005; 10(7): E050714.6 (http://www.eurosurveillance.org/ew/2005/050714.asp#6).
124. Pozio E. New patterns of Trichinella infection. Veterinary Parasitology 2001; 98: 133-148.
125. Ozeretskovskaya NN, et al. New trends and clinical patterns of human trichinellosis in Russia at the beginning of the XXI century. Veterinary Parasitology 2005; 132: 167-171.
126. Djordjevic M, et al. The need for implementation of International Commission on Trichinellosis recommendations, quality assurance standards, and proficiency sample programs in meat inspection for trichinellosis in Serbia. Veterinary Parasitology 2005; 132 185-188.
127. Cortes-Blanco M, et al. Outbreak of trichinellosis in Caceres, Spain, December 2001-February 2002. Eurosurveillance 2002; 7: 136-138.
128. Gomez-Garcia V, Hernandez-Quero J, Rodriguez-Osorio M. Short report: Human infection with Trichinella britovi in Granada, Spain. American Journal of Tropical Medicine and Hygiene 2003; 68: 463-464.
129. Gari-Toussaint M, et al. Human trichinellosis due to Trichinella britovi in southern France after consumption of frozen wild boar meat. Eurosurveillance 2005; 10: 117-118.
130. Pozio E, et al. Trichinella pseudospiralis foci in Sweden. Veterinary Parasitology 2004; 125: 335-342.
131. Hurnikova Z, et al. First record of Trichinella pseudospiralis in the Slovak Republic found in domestic focus. Veterinary Parasitology 2005; 128: 91-98.
132. Janovsky M, et al. Echinococcus multilocularis in a European beaver from Switzerland. Journal of Wildlife Diseases 2002; 38: 618-620.
133. Boucher JM et al. Detection of Echinococcus multilocularis in wild boars in France using PCR techniques against larval form. Veterinary Parasitology 2005; 129: 259-266.
134. Martinek K, et al. Echinococcus multilocularis in European wolves (Canis lopus). Parasitology Research 2001; 87 838-839.
135. Hofer S, et al. High prevalence of Echinococcus multilocularis in urban red foxes (Vulpes vulpes) and voles ( Arvicola terrestris) in the city of Zurich, Switzerland. Parasitology 2000; 120: 135-142.
136. Sreter T, et al. Echinococcus multilocularis: An emerging pathogen in Hungary and Central Eastern Europe? Emerging Infectious Diseases 2003; 9: 384-386.
137. Moks E, Saarma U, Valdmann H. Echinococcus multilocularis in Estonia. Emerging Infectious Diseases 2005; 11: 1973-1974.
138. Deplazes P, et al. Wilderness in the city: The urbanization of Echinococcus multilocularis. Trends of Parasitology 2004; 20 77-84.
139. Deplazes P, Eckert J. Veterinary aspects of alveolar echinococcosis a zoonosis of public health significance. Veterinary Parasitology 2001; 98: 65-87.
140. Kern P, et al. European echinococcosis registry: Human alveolar echinococcosis, Europe, 1982 2000. Emerging Infectious Diseases 2003; 9: 343-349.
141. Mendez Martinez C, et al. Brucellosis outbreak due to unpasteurized raw goat cheese in Andalucia (Spain), January March 2002. Eurosurveillance 2003; 8: 164-168.
142. Al Dahouk S, et al. Human brucellosis in a non-endemic country: A report from Germany, 2002 and 2003. European Journal of Clinical Microbiology and Infectious Diseases 2005; 24: 450-456.
143. Malik AN, et al. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004. Emerging Infectious Diseases 2006; 12: 1257-1259.
144. Desjeux P, Alvar J. Leishmania/HIV co-infections: Epidemiology in Europe. Annals of Tropical Medicine and Parasitology 2003; 97 (Suppl. 1): 3-15.
145. Gabutti G, et al. Visceral leishmaniasis in Liguria, Italy. Lancet 1998; 351: 1136.
146. WHO. Urbanization: An increasing risk factor for leishmaniasis. Weekly Epidemiological Record 2002; 77: 365-372 (http://www.who.int/wer).
147. Ferroglio E, et al. Canine leishmaniasis, Italy. Emeraging Infectious Diseases 2005; 11: 1618-1620.
148. Paradies P, et al. Incidences of canine leishmaniasis in an endemic area of southern Italy. Journal of Veterinary Medicine, B: Infectious Diseases and Veterinary Public Health 2006; 53: 295-298.
149. Lindgren E, Talleklint L, Polfeldt T. Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus. Environmental health perspectives 2000; 108: 119-123.
150. McMichael AJ, Woodruff RE, Hales S. Climate change and human health: Present and future risks. Lancet 2006; 367: 859-869.
151. Cinco M, et al. Seroprevalence of tick-borne infections in forestry rangers from northeastern Italy. Clinical Microbiology and Infection (the official publication of the European Society of Clinical Microbiology and Infectious Diseases) 2004; 10: 1056-1061.
152. Foucault C, et al. Bartonella quintana bacteremia among homeless People. Clinical Infectious Diseases 2002; 35 684 689.
153. Fournier PE, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: A study of 48 patients. Medicine (Baltimore) 2001; 80: 245-251.
154. Santos R, et al. Bacillary angiomatosis by Bartonella quintana in an HIV-infected patient. Journal of American Academy of Dermatology 2000; 42: 299-301.
155. Ruscio M, Cinco M. Human granulocytic ehrlichiosis in Italy: First report on two confirmed cases. Annals of the New York Academy of Sciences 2003; 990: 350-352.
156. Remy V, et al. Human anaplasmosis presenting as atypical pneumonitis in France. Emerging Infectious Diseases 2003; 37 846-848.
157. Arnez M, et al. Causes of febrile illnesses after a tick bite in Slovenian children. Pediatric Infectious Diseases Journal 2003; 22: 1078-1083.
158. Oteo JA, et al. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerging Infectious Diseases 2000; 6: 430-432. [Erratum in: 6 (2000) 562 and 663.
159. Bjoersdorff A, et al. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: Report from a prospective clinical study. Scandinavian Journal of Infectious Diseases 2002; 34: 187-191.
160. Baumann D, et al. Fever after a tick bite: Clinical manifestations and diagnosis of acute tick bite-associated infections in northeastern Switzerland [in German]. Deutsche medizinische Wochenschrift 2003; 128: 1042-1047.
161. Raoult D, et al. Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks. Clinical Infectious Diseases 2002; 34: 1331-1336.
162. Karti SS, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerging Infectious Diseases 2004; 10: 1379-1384.
163. Papa A, Bojovic B, Antoniadis A. Hantaviruses in Serbia and Montenegro. Emerging Infectious Diseases 2006; 12: 1015-1018.
164. Defuentes G, et al. Acute meningitis owing to phlebotomus fever Toscana virus imported to France. Journal of Travel Medicine 2005; 12: 295-296.
165. Haglund M. Occurrence of TBE in areas previously considered being non-endemic: Scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW-TBE). International Journal of Medical Microbiology 2002; 291 (Suppl. 33): 50-54.
166. Regnery RL, Childs JE, Koehler JE. Infections associated with Bartonella species in persons infected with human immunodeficiency virus. Clinical Infectious Diseases 1995; 21 (Suppl. 1): S94 98.
167. Trevejo RT, Barr MC, Robinson RA. Important emerging bacterial zoonotic infections affecting the immunocompromised. Veterinary Research 2005; 36: 493-506.
168. Alberti A, et al. Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States. Applied Environmental Microbiology 2005; 71: 6418-6422.
169. Olsson GE, et al. Habitat factors associated with bank voles (Clethrionomys glareolus) and concomitant hantavirus in northern Sweden. Vector Borne Zoonotic Diseases 2005; 5: 315-323.
170. Malkinson M, Banet C. The role of birds in the ecology of West Nile virus in Europe and Africa. Current Topics in Microbiology and Immunology 2002; 267: 309-322.
171. Martin V, et al. Epidemiology and ecology of highly pathogenic avian influenza with particular emphasis on South East Asia. Developments in Biologicals 2006; 124: 23-36.
172. Gambaryan A, et al. Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 2006; 344: 432 438.
173. Wan XF, et al. Genetic characterization of H5N1 avian influenza viruses isolated in southern China during the 2003-04 avian influenza outbreaks. Archives of Virology 2005; 150: 1257-1266.
174. Taubenberger JK, et al. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437: 889-893.
175. Sims LD, et al. Origin and evolution of highly pathogenic H5N1 avian influenza in Asia. Veterinary Record 2005; 157: 159-164.
176. Gabriel G, et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proceedings of the National Academy of Sciences USA 2005; 102: 18590-18595.
177. World Health Organization. Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza viruses in Asia. Emerging Infectious Diseases 2005; 11: 1515-1521.